Company Filing History:
Years Active: 2021
Title: Dagmar Hildebrand: Innovator in Infection Diagnosis
Introduction
Dagmar Hildebrand is a prominent inventor based in Dossenheim, Germany. She has made significant contributions to the field of medical diagnostics, particularly in the identification of severe infections. Her innovative work has the potential to improve patient outcomes through early detection and treatment.
Latest Patents
Dagmar Hildebrand holds a patent for a method involving delta-like ligand 1 for diagnosing severe infections. This invention pertains to an in vitro diagnostic method that includes determining the presence of delta-like ligand 1 protein or its coding nucleotide sequence in biological samples. An elevated level of delta-like ligand 1 is indicative of severe infections, such as sepsis, making it a valuable biomarker for diagnosis.
Career Highlights
Hildebrand is affiliated with Universität Heidelberg, where she continues her research and development in the field of medical diagnostics. Her work is characterized by a commitment to advancing healthcare through innovative solutions.
Collaborations
She collaborates with notable colleagues, including Klaus Heeg and Florian Uhle, who contribute to her research endeavors and enhance the impact of her inventions.
Conclusion
Dagmar Hildebrand's contributions to the field of infection diagnosis exemplify the importance of innovation in healthcare. Her work not only advances scientific knowledge but also has the potential to save lives through improved diagnostic methods.